The nature of medical regulation makes it extremely expensive to develop a new drug, and considerably less expensive to find a new use for an existing approved drug. Thus repurposing drugs receives more attention than it perhaps should, and the typical outcome is a new marginal use rather than something impressive. This will happen for...